Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer

  • Lucy Heinemann1,
  • Guy R Simpson1,
  • Angela Boxall1,
  • Timothy Kottke2,
  • Kate L Relph1,
  • Richard Vile2,
  • Alan Melcher3,
  • Robin Prestwich3,
  • Kevin J Harrington4,
  • Richard Morgan1 and
  • Hardev S Pandha1Email author
BMC Cancer201111:221

DOI: 10.1186/1471-2407-11-221

Received: 29 November 2010

Accepted: 6 June 2011

Published: 6 June 2011

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
29 Nov 2010 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
29 Nov 2010 Author responded Author comments - Hardev Pandha
Resubmission - Version 3
29 Nov 2010 Submitted Manuscript version 3
17 Dec 2010 Reviewed Reviewer Report - Stephen Thorne
20 Dec 2010 Reviewed Reviewer Report - Randal Johnston
22 Dec 2010 Reviewed Reviewer Report - Pooja Hingorani
18 Jan 2011 Author responded Author comments - Hardev Pandha
Resubmission - Version 4
18 Jan 2011 Submitted Manuscript version 4
20 Jan 2011 Reviewed Reviewer Report - Randal Johnston
25 Jan 2011 Reviewed Reviewer Report - Pooja Hingorani
3 Feb 2011 Reviewed Reviewer Report - Stephen Thorne
23 Feb 2011 Author responded Author comments - Hardev Pandha
Resubmission - Version 5
23 Feb 2011 Submitted Manuscript version 5
Publishing
6 Jun 2011 Editorially accepted
6 Jun 2011 Article published 10.1186/1471-2407-11-221

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Oncology, Postgraduate Medical School, University of Surrey
(2)
Mayo Clinic
(3)
Cancer Research UK Clinical Centre, St James's University Hospital
(4)
Targeted Therapy Team, Institute for Cancer Research, Chester Beatty Laboratories

Advertisement